Hexose-6-phosphate dehydrogenase contributes to skeletal muscle homeostasis independent of 11β-hydroxysteroid dehydrogenase type 1

Endocrinology

Volumn 152, Issue 1, 2011, Pages 93-102

  Semjonous, Nina M ^a   Sherlock, Mark ^a   Jeyasuria, Pancharatnam ^b   Parker, Keith L ^c   Walker, Elizabeth A ^a   Stewart, Paul M ^a   Lavery, Gareth G ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; GLUCOCORTICOID; GLUCOSE 6 PHOSPHATE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; CELL VACUOLE; CONTROLLED STUDY; CORTICOSTEROID METABOLISM; GENE EXPRESSION; GLYCOGEN MUSCLE LEVEL; HOMEOSTASIS; HYPOGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MOUSE; MUSCLE ATROPHY; MYOPATHY; NONHUMAN; OXIDATION REDUCTION STATE; PATHOGENESIS; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ANIMALS; BLOOD GLUCOSE; CARBOHYDRATE DEHYDROGENASES; CORTICOSTERONE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HOMEOSTASIS; INSULIN; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; MUSCULAR DISEASES;

EID: 78650812078     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0957     Document Type: Article

References (33)

1. Hewitt KN, Walker EA, Stewart PM 2005 Minireview: hexose-6-phosphate dehydrogenase and redox control of 11/3-hydroxysteroid dehydrogenase type 1 activity. Endocrinology 146:2539-2543
2. Lavery GG, Walker EA, Turan N, Rogoff D, Ryder JW, Shelton JM, Richardson JA, Falciani F, White PC, Stewart PM, Parker KL, McMillan DR 2008 Deletion of hexose-6-phosphate dehydrogenase activates the unfolded protein response pathway and induces skeletal myopathy. J Biol Chem 283:8453-8461
3. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM 2004 11/3-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 25:831-866
4. Schweizer RA, Zurcher M, Balazs Z, Dick B, Odermatt A 2004 Rapid hepatic metabolism of 7-ketocholesterol by 11/3-hydroxysteroid dehydrogenase type 1: species-specific differences between the rat, human, and hamster enzyme. J Biol Chem 279:18415-18424
5. Wamil M, Andrew R, Chapman KE, Street J, Morton NM, Seckl JR 2008 7-Oxysterols modulate glucocorticoid activity in adipocytes through competition for 11/3-hydroxysteroid dehydrogenase type. Endocrinology 149:5909-5918
6. Lavery GG, Walker EA, Draper N, Jeyasuria P, Marcos J, Shackleton CH, Parker KL, White PC, Stewart PM 2006 Hexose-6-phosphate dehydrogenase knock-out mice lack 11/3-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. J Biol Chem 281: 6546-6551
7. Lavery GG, Hauton D, Hewitt KN, Brice SM, Sherlock M, Walker EA, Stewart PM 2007 Hypoglycemia with enhanced hepatic glycogen synthesis in recombinant mice lacking hexose-6-phosphate dehydrogenase. Endocrinology 148:6100-6106
8. Rogoff D, Ryder JW, Black K, Yan Z, Burgess SC, McMillan DR, White PC 2007 Abnormalities of glucose homeostasis and the hy-pothalamic-pituitary- adrenal axis in mice lacking hexose-6-phos-phate dehydrogenase. Endocrinology 148:5072-5080
9. Whorwood CB, Donovan SJ, Flanagan D, Phillips DI, Byrne CD 2002 Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. Diabetes 51:1066-1075
10. Jang C, Obeyesekere VR, Dilley RJ, Alford FP, Inder WJ 2006 11/3-Hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle. Clin Endocrinol (Oxf) 65: 800-805
11. Zhang M, Lv XY, Li J, Xu ZG, Chen L 2009 Alteration of 11/3-hydroxysteroid dehydrogenase type 1 in skeletal muscle in a rat model of type 2 diabetes. Mol Cell Biochem 324:147-155
12. Aubry EM, Odermatt A 2009 Retinoic acid reduces glucocorticoid sensitivity in C2C12 myotubes by decreasing 11/3-hydroxysteroid dehydrogenase type 1 and glucocorticoid receptor activities. Endocrinology 150:2700-2708
13. Dirks-Naylor AJ, Griffiths CL 2009 Glucocorticoid-induced apo-ptosis and cellular mechanisms of myopathy. J Steroid Biochem Mol Biol 117:1-7
14. Schakman O, Gilson H, Thissen JP 2008 Mechanisms of glucocorticoid- induced myopathy. J Endocrinol 197:1-10
15. Rebuffe-Scrive M, Krotkiewski M, Elfverson J, Bjorntorp P 1988 Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. J Clin Endocrinol Metab 67:1122-1128
16. Stenzel-Poore MP, Cameron VA, Vaughan J, Sawchenko PE, Vale W 1992 Development of Cushing's syndrome in corticotropin-releas-ing factor transgenic mice. Endocrinology 130:3378-3386
17. Andrews RC, Walker BR 1999 Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci (Lond) 96:513-523
18. Ruzzin J, Wagman AS, Jensen J 2005 Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor. Dia-betologia 48:2119-2130
19. Tiley HA, Geor RJ, McCutcheon LJ 2008 Effects of dexamethasone administration on insulin resistance and components of insulin signaling and glucose metabolism in equine skeletal muscle. Am J Vet Res 69:51-58
20. Agarwal AK, Tusie-Luna MT, Monder C, White PC 1990 Expression of 11/3-hydroxysteroid dehydrogenase using recombinant vaccinia virus. Mol Endocrinol 4:1827-1832
21. Lewandoski M, Wassarman KM, Martin GR 1997 Zp3-cre, a transgenic mouse line for the activation or inactivation of loxP-flanked target genes specifically in the female germ line. Curr Biol 7:148-151
22. Shackleton CH, Hughes BA, Lavery GG, Walker EA, Stewart PM 2008 The corticosteroid metabolic profile of the mouse. Steroids 73:1066-1076
23. Walker EA, Clark AM, Hewison M, Ride JP, Stewart PM 2001 Functional expression, characterization, and purification of the catalytic domain of human 11-/3-hydroxysteroid dehydrogenase type 1. J Biol Chem 276:21343-21350
24. Bujalska IJ, Draper N, Michailidou Z, Tomlinson JW, White PC, Chapman KE, Walker EA, Stewart PM 2005 Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11/3-hydroxysteroid dehydrogenase type 1. J Mol Endocrinol 34:675-684
25. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CR, Seckl JR, Mullins JJ 1997 11/3-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci USA 94:14924-14929
26. Harris HJ, Kotelevtsev Y, Mullins JJ, Seckl JR, Holmes MC 2001 Intracellular regeneration of glucocorticoids by 11/3-hydroxysteroid dehydrogenase (11/3-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11/3-HSD-1-defi-cient mice. Endocrinology 142:114-120
27. Schroder M, Kaufman RJ 2005 The mammalian unfolded protein response. Annu Rev Biochem 74:739-789
28. Rogoff D, Black K, McMillan DR, White PC 2010 Contribution of hexose-6-phosphate dehydrogenase to NADPH content and redox environment in the endoplasmic reticulum. Redox Rep 15:64-70
29. Walker EA, Ahmed A, Lavery GG, Tomlinson JW, Kim SY, Cooper MS, Ride JP, Hughes BA, Shackleton CH, McKiernan P, Elias E, Chou JY, Stewart PM 2007 11/3-Hydroxysteroid dehydrogenase type 1 regulation by intracellular glucose 6-phosphate provides evidence for a novel link between glucose metabolism and hypo-thalamo-pituitary-adrenal axis function. J Biol Chem 282:27030-27036
30. Ferrer J C, Favre C, Gomis RR, Fernandez-Novell J M, García-Rocha M, de la Iglesia N, Cid E, Guinovart JJ 2003 Control of glycogen deposition. FEBS Lett 546:127-132
31. Hintz CS, Coyle EF, Kaiser KK, Chi MM, Lowry OH 1984 Comparison of muscle fiber typing by quantitative enzyme assays and by myosin ATPase staining. J Histochem Cytochem 32:655-660
32. Rivero JL, Talmadge RJ, Edgerton VR 1999 Interrelationships of myofibrillar ATPase activity and metabolic properties of myosin heavy chain-based fibre types in rat skeletal muscle. Histochem Cell Biol 111:277-287
33. Bernales S, Papa FR, Walter P 2006 Intracellular signaling by the unfolded protein response. Annu Rev Cell Dev Biol 22:487-508